Physicochemical Properties
| Molecular Formula | C3H4N2 |
| Molecular Weight | 68.08 |
| Exact Mass | 68.037 |
| CAS # | 288-13-1 |
| Related CAS # | 105809-46-9 |
| PubChem CID | 1048 |
| Appearance | Off-white to light brown solid powder |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 187.0±9.0 °C at 760 mmHg |
| Melting Point | 67-70 °C(lit.) |
| Flash Point | 87.5±11.7 °C |
| Vapour Pressure | 0.9±0.3 mmHg at 25°C |
| Index of Refraction | 1.528 |
| LogP | 0.32 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 5 |
| Complexity | 28.1 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WTKZEGDFNFYCGP-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C3H4N2/c1-2-4-5-3-1/h1-3H,(H,4,5) |
| Chemical Name | 1H-pyrazole |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Additional Infomation |
1H-pyrazole is the 1H-tautomer of pyrazole. It is a conjugate base of a pyrazolium. It is a conjugate acid of a pyrazol-1-ide. It is a tautomer of a 3H-pyrazole and a 4H-pyrazole. Pyrazole has been reported in Glycyrrhiza glabra with data available. Pyrazole is a heterocyclic organic compound characterized by a ring structure composed of three carbon atoms and two nitrogen atoms in adjacent positions, with the molecular formula C3H4N2. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (1468.86 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 14.6886 mL | 73.4430 mL | 146.8860 mL | |
| 5 mM | 2.9377 mL | 14.6886 mL | 29.3772 mL | |
| 10 mM | 1.4689 mL | 7.3443 mL | 14.6886 mL |